Standout Papers

Talquetamab, a T-Ce... 2006 2026 2012 2019 545
  1. Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma (2022)
    Ajai Chari, Monique C. Minnema et al. New England Journal of Medicine
  2. Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma (2006)
    Richard I. Fisher, Steven H. Bernstein et al. Journal of Clinical Oncology

Immediate Impact

5 by Nobel laureates 29 from Science/Nature 68 standout
Sub-graph 1 of 21

Citing Papers

Engineered skin bacteria induce antitumor T cell responses against melanoma
2023 StandoutScience
CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
2 intermediate papers

Works of Amrita Krishnan being referenced

Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor–Redirected T Cells Against Multiple Myeloma
2017

Author Peers

Author Last Decade Papers Cites
Amrita Krishnan 2844 2742 2135 198 5.4k
Ulrich Jäger 2329 1618 1799 173 5.5k
Johannes Drach 3168 3145 3341 175 7.3k
Maurice Barcos 1755 2854 1633 136 6.4k
Gary Spitzer 3258 2938 1325 216 7.2k
Monique C. Minnema 2811 2030 1789 226 5.4k
Luciano J. Costa 3073 2326 1849 252 4.6k
Christopher D. Gocke 1266 1953 2134 184 5.6k
Patrick J. Stiff 3164 4042 1344 238 8.2k
David P. Schenkein 3652 2796 3846 114 7.3k
Robert Vescio 2906 2981 2918 149 5.9k

All Works

Loading papers...

Rankless by CCL
2026